TIANXIN PHARMA(SH:603235) Xin Lang Cai Jing·2025-10-31 02:49Core Viewpoint - Tianxin Pharmaceutical (603235.SH) reported its Q3 2025 results, highlighting a slight decrease in institutional investor holdings compared to the previous quarter [1] Institutional Holdings - As of October 30, 2025, five institutional investors disclosed holdings in Tianxin Pharmaceutical, totaling 28.4284 million shares, which represents 6.49% of the company's total share capital [1] - The institutional holding percentage decreased by 0.06 percentage points compared to the previous quarter [1] Public Fund Holdings - One new public fund disclosed its holdings this quarter, namely the Huaxia CSI 800 Index Enhanced A [1] - A total of 34 public funds were not disclosed this quarter, including notable funds such as the Huitianfu CSI 300 Index Enhanced A and the Southern High Dividend Theme Stock A [1]